Rheumatoid Arthritis & Seronegative Spondyloarthropathies Flashcards
RA is an autoimmune disease that targets _____ tissues in _______ joints
Synovial; diarthrodial
Systemic features of RA
Fatigue, fever, normochromic normocytic anemia
Elevated APPs (ESR, CRP)
Constitutional sxs: malaise, myalgia, depression
1/3 of pts are susceptible to RA d/t genetic factors — typically _______ alleles
HLA-DRB 4
T/F: pathologic changes in joints precede synovitis in RA pts by 5-10 years
True
Initial pathogenesis of RA involves infiltration of leukocytes, cytokines, and macrophages that act as APCs to activate _____ cells.
Later _____ cells produce autoantibodies, and proinflammatory cytokines promote synovial proliferation, increase synovial fluid, and lead to _______ formation that invades cartilage and bone
T
B; pannus
Imaging studies to order when RA is suspected
X-rays of hands and feet — detect symmetrical involvement of MCP/MTP joints; erosions
CT is more sensitive in detecting erosions!!
Treatment for RA that presents acutely
Begin NSAID for pain control
Early use of DMARD
May need low dose steroid for a few weeks
Monitor progress and toxicity
How does RA change during pregnancy?
Improves; then flares 4-6 weeks post partum
Significant mortality caused by infection, renal disease, GI disease, heart disease, and malignancy is associated with RA moreso than the general population.
What are cardiac mortality associations with RA?
CAD, CHF due to endothelial damage from chronic inflammation
In terms of the 2010 RA Classification Criteria, the target population of those who should be tested are patients who:
Have at least 1 joint with definite clinical ______ that is not better explained by another disease
Synovitis
What are the 4 class criteria utilized in the 2010 RA Classification Criteria?
Joint involvement (number and size)
Serology (at least 1 positive test — RF, CCP)
Acute phase reactants (at least 1 test needed — CRP, ESR)
Duration of symptoms (>6 weeks gets a point)
[greater than 6/10 points = definite RA]
What lab values are used to monitor treatment response in RA?
Acute phase reactants (ESR, CRP)
What part of the spine is affected by RA?
C1-C2 — be careful with flexion and hyperextension; tell anesthesiologist before intubation d/t risk of subluxation!
[the remainder of the axial spine is SPARED!]
T/F: RA pts have decreased risk of osteoporosis
False, they have increased risk
______ deviation of the wrist in RA in addition to synovial proliferation may lead to compression of the ____ nerve and subsequent carpal tunnel syndrome
Radial; median
Knee manifestations of RA
Bakers cyst — popliteal region
Diagnosis of RA typically requires active signs of inflammation of at least _________ duration
6 weeks
Complication of RA characterized by tender reddish purple papule; leads to necrotic, non-healing ulcer
Pyoderma gangrenosum
Purpura, petechiae, splinter hemorrhages, and digital infarcts are characteristic of rheumatoid ______
Vasculitis
T/F: Rheumatoid arthritis is an independent risk factor for CAD
True
_____ syndrome = nodular lung densities after exposure to coal or silica dust
Caplan
Sjogren’s syndrome is seen in 35% of pts with RA. What are 3 tests that may be used to support a dx of Sjogrens?
Ro/SS-a, La/SS-b Abs
Schirmers test (litmus paper under eyelids to test for tear production)
Slit-lamp exam
Rheumatoid arthritis Splenomegaly Thrombocytopenia Neutropenia Fever Anemia RF and anti-CCP positive
Felty’s syndrome
RA may be complicated by atlantoaxial subluxation (C1/C2) due to erosion of the _________ _______; other complications include peripheral neuropathy and ______ myelopathy
Odontoid process; cervical
In which of the following might rheumatoid factor be positive?
A. Healthy elderly patient B. Hepatitis B/C pts C. CTD/SLE D. Polymyositis E. Sjogrens F. Systemic sclerosis G. Lymphoma or myeloma H. TB, mono, syphilis, and sarcoid I. All of the above
I. All of the above
Immunosuppresive drug class utilized in RA that can halt disease progression in synovium and halt/slow radiographic progression; treat to target — remission or low disease activity
DMARDs